- Home
- KRUS vs CDNA Comparison
KRUS vs CDNA Comparison
Compare KRUS & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRUS
- CDNA
- Stock Information
- Founded
- KRUS 2008
- CDNA 1998
- Country
- KRUS United States
- CDNA United States
- Employees
- KRUS N/A
- CDNA N/A
- Industry
- KRUS Restaurants
- CDNA Medical Specialities
- Sector
- KRUS Consumer Discretionary
- CDNA Health Care
- Exchange
- KRUS Nasdaq
- CDNA Nasdaq
- Market Cap
- KRUS 1.0B
- CDNA 1.1B
- IPO Year
- KRUS 2019
- CDNA 2014
- Fundamental
- Price
- KRUS $78.74
- CDNA $22.70
- Analyst Decision
- KRUS Buy
- CDNA Buy
- Analyst Count
- KRUS 8
- CDNA 8
- Target Price
- KRUS $89.75
- CDNA $26.43
- AVG Volume (30 Days)
- KRUS 153.9K
- CDNA 851.0K
- Earning Date
- KRUS 01-07-2025
- CDNA 02-26-2025
- Dividend Yield
- KRUS N/A
- CDNA N/A
- EPS Growth
- KRUS N/A
- CDNA N/A
- EPS
- KRUS N/A
- CDNA N/A
- Revenue
- KRUS $250,841,000.00
- CDNA $312,775,000.00
- Revenue This Year
- KRUS $20.76
- CDNA $19.85
- Revenue Next Year
- KRUS $23.25
- CDNA $11.34
- P/E Ratio
- KRUS N/A
- CDNA N/A
- Revenue Growth
- KRUS 25.68
- CDNA 5.26
- 52 Week Low
- KRUS $48.66
- CDNA $7.42
- 52 Week High
- KRUS $122.81
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- KRUS 36.22
- CDNA 50.19
- Support Level
- KRUS $73.34
- CDNA $21.09
- Resistance Level
- KRUS $87.72
- CDNA $25.95
- Average True Range (ATR)
- KRUS 6.07
- CDNA 1.67
- MACD
- KRUS -1.80
- CDNA 0.04
- Stochastic Oscillator
- KRUS 16.24
- CDNA 41.96
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.